Utah legislation · 2026 General Session
Utah SB222: Right to Try Amendments
Status: Signed into law, March 18, 2026
This bill amends provisions related to when a patient may obtain and use investigational drugs and devices to treat an illness.
What the bill says
From the enrolled text, March 11, 2026:
0 Right to Try Amendments 2026 GENERAL SESSION STATE OF UTAH Chief Sponsor: Chris H. Wilson House Sponsor: Tyler Clancy LONG TITLE General Description: This bill amends provisions related to when a patient may obtain and use investigational drugs and devices to treat an illness. Highlighted Provisions: This bill: - allows a patient to obtain an investigational drug or device in additional circumstances; - amends the definition regarding the forms a medicine may take; and - creates a reporting requirement for manufacturers. Money Appropriated in this Bill: None Other Special Clauses: None Utah Code Sections Affected: AMENDS: 58-85-102 , as last amended by Laws of Utah 2025, Chapter 114 ENACTS: 58-85-107 , Utah Code Annotated 1953 Be it enacted by the Legislature of the state of Utah: Section 1. Section 58-85-102 is amended to read: 58-85-102 . Definitions. As used in this chapter: (1) "Eligible illness" means a condition of a patient that: (a) as determined by a physician, presents a substantial and severely debilitating or life-threatening risk to the patient; and (b) presents the patient, after the patient has explored conventional therapy options, with no treatment option that is satisfactory or comparable to treatment with an investigational drug or investigational device. (2) "Eligible patient" means an individual who has been diagnosed with a terminal illness or eligible illness by …
Sponsors
- Wilson, Chris H. (R, 2) · primary sponsor
- Tyler Clancy (R, 60)
Latest actions
- : Governor Signed
- : Senate/ to Governor
- : Senate/ received enrolled bill from Printing
- : Senate/ enrolled bill to Printing
- : Enrolled Bill Returned to House or Senate
- : Draft of Enrolled Bill Prepared
- : Bill Received from Senate for Enrolling
- : Senate/ signed by President/ sent for enrolling
- : Senate/ received from House
- : House/ to Senate
Votes
- House/ passed 3rd reading (March 5, 2026): 67 yea, 0 nay, passed
- House Comm - Favorable Recommendation (February 27, 2026): 10 yea, 0 nay, passed
- Senate/ passed 3rd reading (February 23, 2026): 24 yea, 0 nay, passed
- Senate/ passed 2nd reading (February 20, 2026): 23 yea, 0 nay, passed
- Senate Comm - Favorable Recommendation (February 3, 2026): 3 yea, 1 nay, passed
Subjects: Health Care, Health and Human Services
Common questions
- What is SB222?
- SB222 is a bill in the Utah Legislature (2026 General Session): Right to Try Amendments.
- What does SB222 do?
- This bill amends provisions related to when a patient may obtain and use investigational drugs and devices to treat an illness.
- What is the status of SB222?
- Signed into law as of March 18, 2026. Latest action: Governor Signed (March 18, 2026).
- Who sponsored SB222?
- Wilson, Chris H. (R, 2), with 1 co-sponsor.
- Where is the official record for SB222?
- On the Utah Legislature website: https://le.utah.gov/~2026/bills/static/SB0222.html
Source: official Utah record. Tracked by Delilah, AI for legislation across all 50 states and Congress.